Critical role of antimicrobial peptide cathelicidin for controlling helicobacter pylori survival and infection

Journal of Immunology

Volumn 196, Issue 4, 2016, Pages 1799-1809

  Zhang, Lin ^a,b   Wu, William K K ^a   Gallo, Richard L ^c   Fang, Evandro F ^d   Hu, Wei ^b   Ling, Thomas K W ^e   Shen, Jing ^b   Chan, Ruby L Y ^b   Lu, Lan ^b   Luo, Xiao M ^b   Li, Ming X ^b   Chan, Kam M ^b   Yu, Jun ^a,b   Wong, Vincent W S ^a,b   Ng, Siew C ^a,b   Wong, Sunny H ^a,b   Chan, Francis K L ^a,b   Sung, Joseph J Y ^a,b   Chan, Matthew T V ^a   Cho, Chi H ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Prince of Wales Hospital   (Hong Kong)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; CATHELICIDIN ANTIMICROBIAL PEPTIDE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BIOFILM; CONTROLLED STUDY; GASTRIC MUCOSA; GASTRITIS; GROWTH INHIBITION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTESTINE MUCOSA PERMEABILITY; LACTOCOCCUS LACTIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; ANIMAL; CELL LINE; DISEASE MODEL; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; IMMUNOLOGY; KNOCKOUT MOUSE; MICROBIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY;

ANIMALS; CATHELICIDINS; CELL LINE; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, SCANNING; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84958582334     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500021     Document Type: Article

References (61)

1. Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 321: 1311-1315.
2. Suerbaum, S., and C. Josenhans. 2007. Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat. Rev. Microbiol. 5: 441-452.
3. Arnold, M., H. E. Karim-Kos, J. W. Coebergh, G. Byrnes, A. Antilla, J. Ferlay, A. G. Renehan, D. Forman, and I. Soerjomataram. 2015. Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory. Eur. J. Cancer 51: 1164-1187.
4. Helicobacter and Cancer Collaborative Group. 2001. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 49: 347-353.
5. Wu, W., Y. Yang, and G. Sun. 2012. Recent insights into antibiotic resistance in Helicobacter pylori eradication. Gastroenterol. Res. Pract. 2012: 723183.
6. Su, P., Y. Li, H. Li, J. Zhang, L. Lin, Q. Wang, F. Guo, Z. Ji, J. Mao, W. Tang, et al. 2013. Antibiotic resistance of Helicobacter pylori isolated in the southeast coastal region of China. Helicobacter 18: 274-279.
7. Gerrits, M. M., A. H. van Vliet, E. J. Kuipers, and J. G. Kusters. 2006. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect. Dis. 6: 699-709.
8. Hall-Stoodley, L., J. W. Costerton, and P. Stoodley. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2: 95-108.
9. Vandamme, D., B. Landuyt, W. Luyten, and L. Schoofs. 2012. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell. Immunol. 280: 22-35.
10. Cammarota, G., M. Sanguinetti, A. Gallo, and B. Posteraro. 2012. Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection. Aliment. Pharmacol. Ther. 36: 222-230.
11. Yonezawa, H., T. Osaki, S. Kurata, C. Zaman, T. Hanawa, and S. Kamiya. 2010. Assessment of in vitro biofilm formation by Helicobacter pylori. J. Gastroenterol. Hepatol. 25(Suppl. 1): S90-S94.
12. Carron, M. A., V. R. Tran, C. Sugawa, and J. M. Coticchia. 2006. Identification of Helicobacter pylori biofilms in human gastric mucosa. J. Gastrointest. Surg. 10: 712-717.
13. Coticchia, J. M., C. Sugawa, V. R. Tran, J. Gurrola, E. Kowalski, and M. A. Carron. 2006. Presence and density of Helicobacter pylori biofilms in human gastric mucosa in patients with peptic ulcer disease. J. Gastrointest. Surg. 10: 883-889.
14. Hurdle, J. G., A. J. O'Neill, I. Chopra, and R. E. Lee. 2011. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat. Rev. Microbiol. 9: 62-75.
15. Gursoy, U. K., M. Pöllänen, E. Könönen, and V. J. Uitto. 2012. A novel organotypic dento-epithelial culture model: effect of Fusobacterium nucleatum biofilm on B-defensin-2,-3, and LL-37 expression. J. Periodontol. 83: 242-247.
16. Nagant, C., B. Pitts, K. Nazmi, M. Vandenbranden, J. G. Bolscher, P. S. Stewart, and J. P. Dehaye. 2012. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments. Antimicrob. Agents Chemother. 56: 5698-5708.
17. López-García, B., P. H. Lee, K. Yamasaki, and R. L. Gallo. 2005. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J. Invest. Dermatol. 125: 108-115.
18. Cobo, E. R., C. He, K. Hirata, G. Hwang, U. Tran, L. Eckmann, R. L. Gallo, and S. L. Reed. 2012. Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing. Infect. Immun. 80: 143-149.
19. Crack, L. R., L. Jones, G. N. Malavige, V. Patel, and G. S. Ogg. 2012. Human antimicrobial peptides LL-37 and human b-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus. Clin. Exp. Dermatol. 37: 534-543.
20. Wang, G., K. M. Watson, and R. W. Buckheit, Jr. 2008. Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins. Antimicrob. Agents Chemother. 52: 3438-3440.
21. Wong, J. H., A. Legowska, K. Rolka, T. B. Ng, M. Hui, C. H. Cho, W. W. Lam, S. W. Au, O. W. Gu, and D. C. Wan. 2011. Effects of cathelicidin and its fragments on three key enzymes of HIV-1. Peptides 32: 1117-1122.
22. Kanthawong, S., J. G. Bolscher, E. C. Veerman, J. van Marle, H. J. de Soet, K. Nazmi, S. Wongratanacheewin, and S. Taweechaisupapong. 2012. Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei. Int. J. Antimicrob. Agents 39: 39-44.
23. Dean, S. N., B. M. Bishop, and M. L. van Hoek. 2011. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol. 11: 114.
24. Zhang, L., J. Yu, C. C. Wong, T. K. Ling, Z. J. Li, K. M. Chan, S. X. Ren, J. Shen, R. L. Chan, C. C. Lee, et al. 2013. Cathelicidin protects against Helicobacter pylori colonization and the associated gastritis in mice. Gene Ther. 20: 751-760.
25. Bals, R., X. Wang, M. Zasloff, and J. M. Wilson. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95: 9541-9546.
26. Djordjevic, D., M. Wiedmann, and L. A. McLandsborough. 2002. Microtiter plate assay for assessment of Listeria monocytogenes biofilm formation. Appl. Environ. Microbiol. 68: 2950-2958.
27. Latorre, A. A., J. A. Van Kessel, J. S. Karns, M. J. Zurakowski, A. K. Pradhan, K. J. Boor, E. Adolph, S. Sukhnanand, and Y. H. Schukken. 2011. Increased in vitro adherence and on-farm persistence of predominant and persistent Listeria monocytogenes strains in the milking system. Appl. Environ. Microbiol. 77: 3676-3684.
28. Jurcisek, J. A., A. C. Dickson, M. E. Bruggeman, and L. O. Bakaletz. 2011. In vitro biofilm formation in an 8-well chamber slide. J. Vis. Exp. 2011: pii: 2481.
29. Stoffel, M. H., A. E. Friess, A. Burnens, A. Schmassmann, and R. Neiger. 2000. Distinction of gastric Helicobacter spp. in humans and domestic pets by scanning electron microscopy. Helicobacter 5: 232-239.
30. Su, B., S. Johansson, M. Fällman, M. Patarroyo, M. Granström, and S. Normark. 1999. Signal transduction-mediated adherence and entry of Helicobacter pylori into cultured cells. Gastroenterology 117: 595-604.
31. Dixon, M. F., R. M. Genta, J. H. Yardley, and P. Correa. 1996. Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20: 1161-1181.
32. Strempel, N., A. Neidig, M. Nusser, R. Geffers, J. Vieillard, O. Lesouhaitier, G. Brenner-Weiss, and J. Overhage. 2013. Human host defense peptide LL-37 stimulates virulence factor production and adaptive resistance in Pseudomonas aeruginosa. PLoS One 8: e82240. doi:10.1371/journal.pone.0082240
33. Tai, E. K., W. K. Wu, X. J. Wang, H. P. Wong, L. Yu, Z. J. Li, C. W. Lee, C. C. Wong, J. Yu, J. J. Sung, et al. 2013. Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp2/2 mice. Gene Ther. 20: 187-193.
34. Tai, E. K., W. K. Wu, H. P. Wong, E. K. Lam, L. Yu, and C. H. Cho. 2007. A new role for cathelicidin in ulcerative colitis in mice. Exp. Biol. Med. (Maywood) 232: 799-808.
35. Wong, C. C., L. Zhang, Z. J. Li, W. K. Wu, S. X. Ren, Y. C. Chen, T. B. Ng, and C. H. Cho. 2012. Protective effects of cathelicidin-encoding Lactococcus lactis in murine ulcerative colitis. J. Gastroenterol. Hepatol. 27: 1205-1212.
36. Zelezetsky, I., A. Pontillo, L. Puzzi, N. Antcheva, L. Segat, S. Pacor, S. Crovella, and A. Tossi. 2006. Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. J. Biol. Chem. 281: 19861-19871.
37. Yuk, J. M., D. M. Shin, H. M. Lee, C. S. Yang, H. S. Jin, K. K. Kim, Z. W. Lee, S. H. Lee, J. M. Kim, and E. K. Jo. 2009. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6: 231-243.
38. Thennarasu, S., A. Tan, R. Penumatchu, C. E. Shelburne, D. L. Heyl, and A. Ramamoorthy. 2010. Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37. Biophys. J. 98: 248-257.
39. Hase, K., M. Murakami, M. Iimura, S. P. Cole, Y. Horibe, T. Ohtake, M. Obonyo, R. L. Gallo, L. Eckmann, and M. F. Kagnoff. 2003. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 125: 1613-1625.
40. Kanthawong, S., J. G. Bolscher, E. C. Veerman, J. van Marle, K. Nazmi, S. Wongratanacheewin, and S. Taweechaisupapong. 2010. Antimicrobial activities of LL-37 and its truncated variants against Burkholderia thailandensis. Int. J. Antimicrob. Agents 36: 447-452.
41. Souto, R., and A. P. Colombo. 2008. Detection of Helicobacter pylori by polymerase chain reaction in the subgingival biofilm and saliva of non-dyspeptic periodontal patients. J. Periodontol. 79: 97-103.
42. Yang, F. L., A. M. Hassanbhai, H. Y. Chen, Z. Y. Huang, T. L. Lin, S. H. Wu, and B. Ho. 2011. Proteomannans in biofilm of Helicobacter pylori ATCC 43504. Helicobacter 16: 89-98.
43. Irie, Y., B. R. Borlee, J. R. O'Connor, P. J. Hill, C. S. Harwood, D. J. Wozniak, and M. R. Parsek. 2012. Self-produced exopolysaccharide is a signal that stimulates biofilm formation in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 109: 20632-20636.
44. Salama, N. R., M. L. Hartung, and A. Muller. 2013. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat. Rev. Microbiol. 11: 385-399.
45. Jiménez-Soto, L. F., S. Rohrer, U. Jain, C. Ertl, X. Sewald, and R. Haas. 2012. Effects of cholesterol on Helicobacter pylori growth and virulence properties in vitro. Helicobacter 17: 133-139.
46. Saito, N., K. Konishi, F. Sato, M. Kato, H. Takeda, T. Sugiyama, and M. Asaka. 2003. Plural transformation-processes from spiral to coccoid Helicobacter pylori and its viability. J. Infect. 46: 49-55.
47. Yamasaki, K., A. Di Nardo, A. Bardan, M. Murakami, T. Ohtake, A. Coda, R. A. Dorschner, C. Bonnart, P. Descargues, A. Hovnanian, et al. 2007. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med. 13: 975-980.
48. Mannam, P., K. F. Jones, and B. L. Geller. 2004. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect. Immun. 72: 3444-3450.
49. Ravnikar, M., B. Strukelj, N. Obermajer, M. Lunder, and A. Berlec. 2010. Engineered lactic acid bacterium Lactococcus lactis capable of binding antibodies and tumor necrosis factor a. Appl. Environ. Microbiol. 76: 6928-6932.
50. Watson, D., R. D. Sleator, C. Hill, and C. G. Gahan. 2008. Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract. BMC Microbiol. 8: 176.
51. Guang, W., H. Ding, S. J. Czinn, K. C. Kim, T. G. Blanchard, and E. P. Lillehoj. 2010. Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen. J. Biol. Chem. 285: 20547-20557.
52. Hollingsworth, M. A., and B. J. Swanson. 2004. Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 4: 45-60.
53. Vinall, L. E., M. King, M. Novelli, C. A. Green, G. Daniels, J. Hilkens, M. Sarner, and D. M. Swallow. 2002. Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology 123: 41-49.
54. McGuckin, M. A., A. L. Every, C. D. Skene, S. K. Linden, Y. T. Chionh, A. Swierczak, J. McAuley, S. Harbour, M. Kaparakis, R. Ferrero, and P. Sutton. 2007. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology 133: 1210-1218.
55. Carvalho, F., R. Seruca, L. David, A. Amorim, M. Seixas, E. Bennett, H. Clausen, and M. Sobrinho-Simoes. 1997. MUC1 gene polymorphism and gastric cancer-an epidemiological study. Glycoconj. J. 14: 107-111.
56. Babu, S. D., V. Jayanthi, N. Devaraj, C. A. Reis, and H. Devaraj. 2006. Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol. Cancer 5: 10.
57. Tarang, S., S. Kumar, and S. K. Batra. 2012. Mucins and Toll-like receptors: kith and kin in infection and cancer. Cancer Lett. 321: 110-119.
58. Navabi, N., M. E. Johansson, S. Raghavan, and S. K. Lindén. 2013. Helicobacter pylori infection impairs the mucin production rate and turnover in the murine gastric mucosa. Infect. Immun. 81: 829-837.
59. Tai, E. K., H. P. Wong, E. K. Lam, W. K. Wu, L. Yu, M. W. Koo, and C. H. Cho. 2008. Cathelicidin stimulates colonic mucus synthesis by up-regulating MUC1 and MUC2 expression through a mitogen-activated protein kinase pathway. J. Cell. Biochem. 104: 251-258.
60. Ko, G. H., S. M. Kang, Y. K. Kim, J. H. Lee, C. K. Park, H. S. Youn, S. C. Baik, M. J. Cho, W. K. Lee, and K. H. Rhee. 1999. Invasiveness of Helicobacter pylori into human gastric mucosa. Helicobacter 4: 77-81.
61. Klaamas, K., O. Kurtenkov, S. von Mensdorff-Pouilly, L. Shljapnikova, L. Miljukhina, V. Brjalin, and A. Lipping. 2007. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer. Immunol. Invest. 36: 371-386.